Indolands Pharma Private Limited, a active private limited company, was established on 05 December 2011 in Dwarka, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2011PTC228266. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Parminder Singh (Director), Balvinder Kaur (Director). Past directors included Balvinder Kaur, Ramanpreet Kaur, Moussa Felix Macinanke. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No.220, Second Floor, Vardhman Mall Sector-19, Dwarka, Delhi, 110075.
U24232DL2011PTC228266
228266
05 December 2011
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Indolands Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parminder Singh | Director | 05 Dec 2011 | Current |
| Balvinder Kaur | Director | 01 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 01 Feb 2022 | Past |
| Pramod Abcsdd | Director | 28 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indolands Pharma Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 5.98% increase. The company also saw a substantial improvement in profitability, with a 106.73% increase in profit. The company's net worth Soared by an impressive increase of 41.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Indolands Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Indolands Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indolands Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indolands Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Indolands Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Balvinder Kaur was appointed as a Director was appointed as a Director on 01 May 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
Indolands Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Parminder Singh was appointed as a Director was appointed as a Director on 05 Dec 2011 & has been associated with this company since 14 years 18 days . was recorded as a recent event.
Progress on Indolands Pharma Private Limited was registered on 05 Dec 2011 with Roc Delhi & aged 14 years 18 days as per MCA records. was documented.
The CIN of Indolands Pharma Private Limited is U24232DL2011PTC228266.
Indolands Pharma Private Limited is headquartered at Shop No.220, Second Floor, Vardhman Mall Sector-19, Dwarka, Delhi, 110075.
Indolands Pharma Private Limited was incorporated on 05 December 2011.
The current directors of Indolands Pharma Private Limited are
The primary industry of Indolands Pharma Private Limited is Manufacturing.
Indolands Pharma Private Limited is unlisted.
The authorized capital of Indolands Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Indolands Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX